The groundbreaking rise of Viagra has long been a example of pharmaceutical success, yet its legacy within the broader industry now presents questions about future yields . Alternative versions are undercutting patent protection , leading to worries that supporting companies significantly dependent to Viagra's former position could be a dangerous m